𝕏
Latest

Terms of use

The terms that apply when you use PharmaWire.org.

By using www.pharmawire.org (the “site”) you agree to these terms. If you do not agree, please do not use the site.

Information only

PharmaWire.org publishes news and analysis about the pharmaceutical and biotech industries. Nothing on the site is medical advice, investment advice or a recommendation to buy or sell any security. Speak to a qualified professional before making medical or financial decisions.

Accuracy

We work to keep our reporting and data accurate, including the FDA calendar and deal tracker, which draw on public sources such as openFDA, the US Federal Register and company announcements. We cannot guarantee that everything is complete, current or free of errors, and dates and figures may change after publication.

Using our content

The articles, data, design and logo on the site belong to PharmaWire.org or its licensors. You may quote short extracts with attribution to PharmaWire.org and a link to the original article. Please do not republish whole articles or substantial parts of them without our permission.

We link to other websites for reference. We are not responsible for their content or practices.

Liability

The site is provided “as is”. To the extent the law allows, we are not liable for any loss arising from use of, or reliance on, the site or its content. Nothing in these terms limits liability that cannot be limited by law.

Governing law

These terms are governed by the law of England and Wales, and the courts of England and Wales have jurisdiction over any dispute.

Contact

Questions about these terms can be sent to our X account, @PharmaWireNews.

Last updated 17 November 2026.